SYNOVIS LIFE TECHNOLOGIES INC

• Accepted (ET)
• Feb 15SC 13G—
  SYNOVIS LIFE TECHNOLOGIES INC0001135428-12-000048 · 7.7 KB
  SEC(opens sec.gov)
• Feb 148-K—
  Current report0001193125-12-061317 · 83.9 KB
  SEC(opens sec.gov)
• Feb 8SC 13G/A—
  SYNOVIS LIFE TECHNOLOGIES INC0001086364-12-000284 · 13.2 KB
  SEC(opens sec.gov)
• Jan 244—
  Insider trades0001235802-12-000022 · 12.3 KB
  SEC(opens sec.gov)
• Jan 20SC 13G/A—
  SYNOVIS LIFE TECHNOLOGIES INC0001085146-12-000054 · 30.3 KB
  SEC(opens sec.gov)
• Jan 510-K—
  Annual report0001140361-12-001445 · 6.7 MB
  SEC(opens sec.gov)
• Dec 21SC 13D—
  SYNOVIS LIFE TECHNOLOGIES INC0001193125-11-349048 · 69.0 KB
  SEC(opens sec.gov)
• Dec 148-K—
  Current report0001140361-11-057359 · 292.8 KB
  SEC(opens sec.gov)
• Dec 138-K—
  Current report0001140361-11-057162 · 2.4 MB
  SEC(opens sec.gov)
• Nov 9SC 13G—
  SYNOVIS LIFE TECHNOLOGIES INC0001085146-11-001133 · 30.1 KB
  SEC(opens sec.gov)

• BOOR FARIBORZ BOORPresident and COO
• FLOEDER TIMOTHY FVP of Corporate Development
• FRICK MARY LOUVP of Regulatory Affairs
• JOHNSTON EVANVP of Operations
• KOBI WILLIAM GDirector
• KRAMP RICHARD WDirector, President and CEO
• LARSON KAREN GILLESDirector
• MAGNUSON CONNIE LVP Finance and CFO
• ORAY B NICHOLASVP - Research & Development
• POTAMI ANTON RDirector

No tickers on record.

• business

  2575 UNIVERSITY AVENUE

  ST PAUL, MN, 55114-1024

• mailing

  2575 UNIVERSITY AVENUE

  ST PAUL, MN, 55114-1024

• SYNOVIS LIFE TECHNOLOGIES INC2012-01-06
• BIO VASCULAR INC2002-02-12